How often is yervoy administered per dose?

How often is yervoy administered per dose?

Yervoy is given as an intravenous infusion over 30 minutes. Dosing frequency depends on whether it is used alone or combined with other drugs.

When used alone for melanoma, Yervoy is administered at 3 mg/kg every three weeks for up to four doses. [1]

When combined with Opdivo for melanoma, kidney cancer, or colorectal cancer, Yervoy receives 3 mg/kg every three weeks for four doses only, then stops while Opdivo continues alone. [1]

What happens if a dose is missed?
Yervoy has a short half-life, so a missed dose requires immediate rescheduling with an oncology team. The four-dose limit remains unchanged.

How does Yervoy dosing compare with Opdivo alone?
Opdivo alone is administered every two or vier weeks, whereas Yervoy is kept to four infusions spaced three weeks apart. The four-dose restriction on Yervoy limits exposure and reduces long-term risk.

When does Yervoy's patent expire?
Yervoy's patent expires in 2034. Biosimilars are unlikely to enter the market until after this date. [2]

What side effects are patients asking about?
Patients report immune-related adverse events such as colitis, hepatitis, endocrinopathies, and skin reactions. These events can occur during the four-dose period or afterward because Yervoy activates the immune system persistently.